10722951 · Active · incorporated 9 years, 3 months ago · Cambridge
Biotech AI Biotech & Life Sciences Diagnostics Drug Discovery Series A
Mursla Bio develops an AI precision medicine platform using extracellular vesicles for diagnostics, particularly for liver cancer.
See the complete cap table with every shareholder, founder tags, dilution across 40 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.